Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

FDMT

4D Molecular Therapeutics Inc

May 12 • 04:00PM ET

10.34

-0.45 -4.17 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: RGNX VYGR EDIT KOD OCUL

| Held by: XBI VTI IWM VXF IWN IBB KOMP VTWO SCHA DFAS

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.66	Insider Own	10.88%	Shs Outstand	52.27M	Perf Week	6.49%
Market Cap	540.52M	Forward P/E	-	EPS next Y	-3.72	Insider Trans	-0.07%	Shs Float	46.59M	Perf Month	2.99%
Enterprise Value	170.17M	PEG	-	EPS next Q	-0.97	Inst Own	91.30%	Short Float	25.74%	Perf Quarter	13.63%
Income	-160.90M	P/S	6.13	EPS this Y	-60.70%	Inst Trans	21.16%	Short Ratio	15.90	Perf Half Y	-1.52%
Sales	88.24M	P/B	1.20	EPS next Y	4.25%	ROA	-31.28%	Short Interest	11.99M	Perf YTD	37.87%
Book/sh	8.64	P/C	1.38	EPS next 5Y	-14.85%	ROE	-34.92%	52W High	12.34 -16.21%	Perf Year	211.45%
Cash/sh	7.48	P/FCF	-	EPS past 3/5Y	10.05% -2.62%	ROIC	-34.46%	52W Low	3.02 242.38%	Perf 3Y	-42.27%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	200.86% 44.32%	Gross Margin	91.02%	Volatility	8.42% 5.92%	Perf 5Y	-62.50%
Dividend TTM	-	EV/Sales	1.93	EPS Y/Y TTM	20.87%	Oper. Margin	-203.47%	ATR (14)	0.63	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	9.34	Sales Y/Y TTM	383560.87%	Profit Margin	-182.34%	RSI (14)	56.68	Recom	1.40
Dividend Gr. 3/5Y	- -	Current Ratio	9.34	EPS Q/Q	-17.38%	SMA20	5.85%	Beta	2.77	Target Price	27.62
Payout	-	Debt/Eq	0.05	Sales Q/Q	21664.29%	SMA50	9.84%	Rel Volume	0.61	Prev Close	10.79
Employees	196	LT Debt/Eq	0.03	Earnings	May 07 AMC	SMA200	16.90%	Avg Volume	754.09K	Price	10.34
IPO	Dec 11, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	-1.45% 17.76%	Trades		Volume	458,669	Change	-4.17%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)